In vitro inhibition of CYP2D6 activity by fenfluramine.

被引：0
|
作者：
Marcucci, K
Gotschall, R
Kearns, GL
Leeder, JS
机构：
[1] Childrens Mercy Hosp, Sect Clin Pharmacol & Exp Ther, Kansas City, MO 64108 USA
[2] Childrens Mercy Hosp, NICHD, PPRU, Kansas City, MO 64108 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80099-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI99
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [31] Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR
    Hersberger, M
    Marti-Jaun, J
    Rentsch, K
    Hänseler, E
    CLINICAL CHEMISTRY, 2000, 46 (08) : 1072 - 1077
  • [32] CYP2D6 activity in methadone maintenance patients
    Shiran, MR
    Rostami-Hodjegan, A
    Lennard, MS
    Iqbal, MZ
    Lagundoye, O
    Pratt, P
    Seiveright, N
    Tucker, GT
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A54 - A54
  • [33] The effect of TCAs on CYP2D6 activity in vivo
    Szewczuk-Boguslawska, M.
    Kiejna, A.
    Beszlej, J.
    Orzechowska-Juzwenko, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S251 - S251
  • [34] The use of Yohimbine for phenotyping of CYP2D6 activity
    Vay, M.
    Rose, P.
    Meyer, M.
    Mikus, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S24 - S24
  • [35] In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine
    Xu, ZH
    Xie, HG
    Zhou, HH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (04) : 518 - 521
  • [36] Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity
    Dalton, Rachel
    Lee, Seung-been
    Claw, Katrina G.
    Prasad, Bhagwat
    Phillips, Brian R.
    Shen, Danny D.
    Wong, Lai Hong
    Fade, Mitch
    McDonald, Matthew G.
    Dunham, Maitreya J.
    Fowler, Douglas M.
    Rettie, Allan E.
    Schuetz, Erin
    Thornton, Timothy A.
    Nickerson, Deborah A.
    Gaedigk, Andrea
    Thummel, Kenneth E.
    Woodahl, Erica L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 147 - 156
  • [37] Quasi-Irreversible Inhibition of CYP2D6 by Berberine
    Kim, Ha Gyeong
    Lee, Han Sol
    Jeon, Jang Su
    Choi, Young Jae
    Choi, Yeon Jung
    Yoo, So-Yeol
    Kim, Eun-yeong
    Lee, Kiho
    Park, InWha
    Na, MinKyun
    Park, Han-Jin
    Cho, Seung-Woo
    Kim, Jong-Hoon
    Lee, Jae-Young
    Kim, Sang Kyum
    PHARMACEUTICS, 2020, 12 (10) : 1 - 14
  • [38] More data for the CYP2D6 hypothesis?:: The in vivo inhibition of CYP2D6 isoenzyme and extrapyramidal symptoms induced by antidepressants in the elderly
    García-Parajuá, P
    de Ugarte, L
    Baca, E
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (01) : 111 - 112
  • [39] INHIBITION OF CYP2D6 BY BUPROPION IN HEALTHY VOLUNTEERS.
    Duong, A.
    Gufford, B.
    Liu, S.
    Benson, E.
    Lu, J.
    Stoughton, C.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S71 - S71
  • [40] DOSE DEPENDENT CYP2D6 INHIBITION BY BUPROPION AND LEVOMEPROMAZINE
    Haslemo, T.
    Arnestad, M.
    Molden, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 6 - 7
12345